Overnight Digest: Stocks to keep an eye on August 30

Sayali Kotwal
/ Categories: Trending, Mindshare
Overnight Digest: Stocks to keep an eye on August 30

Keep an eye on these stocks in tomorrow's trading session.

 At the time of Monday’s closing bell, the markets tanked, owing to the heavy sell-off prompted by Fed Chairman’s comments on inflation on Friday.  

  At 4 pm, Sensex was at 57,972.62, losing 861.25 points or 1.46 per cent whereas Nifty 50 was at 17,312.90, down by 246 points or 1.40 per cent.  

  In BSE 200 Group, the shares of Adani Transmission, Adani Total Gas, Bharat Electronics, ABB India, and Indian Hotels have made their respective fresh 52-week highs today.    

  Keep a watch on these stocks for Tuesday's trading session –  

 Tata Consultancy Services:  TCS HOBS™ platform has been chosen by Community Fibre, in London, to help modernise its business operations, increase its agility, and support future growth.  Residents, businesses, and communities, throughout the capital, may access 100% full fibre broadband at a reasonable price thanks to Community Fibre. By the end of 2024, the network operator and internet service provider (ISP) expects to serve more than half of the 3.7 million homes in the city. The shares of TCS closed at Rs 3,139.55 a piece, lower by 2.55 per cent on BSE today.  

  

L&T Technology Services:  The European luxury car manufacturer BMW Group has hired L&T Technology Services Limited under a multimillion-dollar, five-year contract to supply high-end technical services for the company's suite of infotainment consoles aimed at its family of hybrid vehicles. For the family of hybrid electric vehicles and the suite of infotainment consoles offered by BMW Group, LTTS has an existing ‘near-shore centre’ that offers engineering and R&D services. The shares of LTTS ended 2.64 per cent lower on BSE today.  

  

Alembic Pharmaceuticals Limited:  US Food & Drug Administration (USFDA) has given its final approval to Alembic Pharmaceuticals Limited (Alembic) for its abbreviated new drug application (ANDA) for Chlorthalidone tablets USP, 25 mg and 50 mg. The reference-listed drug product (RLD), Sanofi Aventis US's Hygroton tablets, 25 mg and 50 mg, and the authorised ANDA are therapeutically comparable (Sanofi).  

Chlorthalidone and other diuretics are recommended for the treatment of hypertension, either as the only therapeutic option or to supplement other antihypertensive medications in cases of more severe hypertension. The scrip ended 0.22 per cent higher at Rs 651.80 today.  

  

Reliance Industries: Reliance Industries (RIL) Chairman Mukesh Ambani declared his company's intention to invest a staggering 2 lakh crore to create its Pan-India genuine 5G network on Monday during the forty-fifth annual general meeting. He claimed that Reliance Jio Infocomm had created the most rapid and ambitious 5G rollout plan ever for the nation. According to Ambani, who was speaking about the 5G launch strategy, "We will launch Jio 5G across numerous significant cities by Diwali of 2022, including the metro cities of Delhi, Mumbai, Chennai, and Kolkata”. The shares of RIL closed 0.72 per cent lower on BSE today.

Rate this article:
3.9

1 comments on article "Overnight Digest: Stocks to keep an eye on August 30"

Avatar image

Swapan Chakraborty

Good

Leave a comment

Add comment

DSIJ MINDSHARE

Mkt Commentary22-Nov, 2024

Mindshare22-Nov, 2024

Mindshare22-Nov, 2024

Bonus and Spilt Shares22-Nov, 2024

Penny Stocks22-Nov, 2024

Knowledge

MF15-Nov, 2024

General15-Nov, 2024

MF14-Nov, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR